paclitaxel has been researched along with Acute Lymphoid Leukemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Chou, TC; Kakadiya, R; Kapuriya, N; Lin, YW; Su, TL; Tsai, TJ; Zhang, X | 1 |
| Chen, GQ; Duan, XF; Wang, XD; Wu, YL; Xu, HZ; Yan, H; Zhao, M; Zhuang, HY | 1 |
| Ostański, M; Sońta-Jakimczyk, D | 1 |
| Colburn, DE; Giles, FJ; Thomas, DA | 1 |
| Khalilzadeh, A; Morris, DL; Pourgholami, MH; Wangoo, KT | 1 |
| Ahmed, T; Darzynkiewicz, Z; Feldman, EJ; Halicka, HD; Lederman, CA; Li, X; Romero, MB; Seiter, K; Traganos, F | 1 |
| Meyer, C | 1 |
| Behm, FG; Campana, D; Consolini, R; Pui, CH; Raimondi, SC | 1 |
| Al-alami, O; Hassan, HT; Martin, JH; Sammons, J | 1 |
| Beyaert, R; Daniel, PT; Dörken, B; Essmann, F; Prokop, A; Schmelz, K; Schulze-Osthoff, K; Wieder, T | 1 |
| Boitnott, JK; Donehower, RC; Hruban, RH; Yardley, JH | 1 |
2 trial(s) available for paclitaxel and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Phase II study of single agent paclitaxel in adult patients with relapsed acute lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2003 |
Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Blast Crisis; DNA Damage; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
9 other study(ies) available for paclitaxel and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Synthesis and in vitro cytotoxicity of 9-anilinoacridines bearing N-mustard residue on both anilino and acridine rings.
Topics: Amsacrine; Aniline Compounds; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Mustard Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2009 |
Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; CDC2 Protein Kinase; Cells, Cultured; Drug Synergism; Humans; Jurkat Cells; Mitosis; Oxides; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tubulin Modulators | 2010 |
[Echocardiographic assessment of circulation system in patients during and 3-5 years after all therapy in childhood].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Case-Control Studies; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Echocardiography; Female; Heart Diseases; Humans; Infant; Male; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Taxoids; Time Factors; Ventricular Function, Left; Ventricular Function, Right | 2002 |
Epothilone-paclitaxel resistant leukemic cells CEM/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways.
Topics: Albendazole; Apoptosis; Base Sequence; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; DNA Primers; Epothilones; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2007 |
On the oncology front.
Topics: Child; Female; Humans; Ovarian Neoplasms; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1993 |
In vitro cytotoxicity of docetaxel in childhood acute leukemias.
Topics: Acute Disease; Adolescent; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Child; Child, Preschool; Docetaxel; Drug Screening Assays, Antitumor; Drug Synergism; Flow Cytometry; Humans; Infant; Karyotyping; Leukemia, Myeloid; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Taxoids; Tumor Cells, Cultured; Vincristine | 1998 |
Divergent effect of taxol on proliferation, apoptosis and nitric oxide production in MHH225 CD34 positive and U937 CD34 negative human leukaemia cells.
Topics: Acute Disease; Antigens, CD34; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; Humans; Leukemia; Leukemia, Myeloid; Nitric Oxide; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1998 |
Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.
Topics: Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Bone Marrow; Carrier Proteins; Caspase 3; Caspase 8; Caspase 9; Caspases; Child; Epirubicin; Fas Ligand Protein; fas Receptor; Fas-Associated Death Domain Protein; Humans; Immunoblotting; Lymphoma, B-Cell; Membrane Glycoproteins; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transfection; Tumor Cells, Cultured | 2001 |
Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest.
Topics: Adult; Aged; Alkaloids; Antineoplastic Agents, Phytogenic; Digestive System; Epithelium; Female; Germ Cells; Humans; Leukemia, Myeloid, Acute; Male; Microtubules; Middle Aged; Mitosis; Necrosis; Ovarian Neoplasms; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testis | 1989 |